
Robert W. Downs
Examiner (ID: 17152)
| Most Active Art Unit | 2308 |
| Art Unit(s) | 2762, 4762, 2309, 2308, 2165 |
| Total Applications | 581 |
| Issued Applications | 448 |
| Pending Applications | 24 |
| Abandoned Applications | 109 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14273911
[patent_doc_number] => 20190134240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => DIMERIZATION STRATEGIES AND COMPOUNDS FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 16/179817
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18356
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16179817
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/179817 | Dimerization strategies and compounds for molecular imaging and/or radioimmunotherapy | Nov 1, 2018 | Issued |
Array
(
[id] => 15828729
[patent_doc_number] => 20200129646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => Radioactive labeled long-acting peptide targeted pharmaceutical and production method thereof
[patent_app_type] => utility
[patent_app_number] => 16/175859
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16175859
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/175859 | Radioactive labeled long-acting peptide targeted pharmaceutical and production method thereof | Oct 30, 2018 | Abandoned |
Array
(
[id] => 20491571
[patent_doc_number] => 12533427
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-27
[patent_title] => Radioactive antitumor agent
[patent_app_type] => utility
[patent_app_number] => 16/758081
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 842
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16758081
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/758081 | Radioactive antitumor agent | Oct 25, 2018 | Issued |
Array
(
[id] => 13982473
[patent_doc_number] => 20190060394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => Therapeutic inhibitor for EBV-associated tumor with tailor responsive optical imaging
[patent_app_type] => utility
[patent_app_number] => 16/170165
[patent_app_country] => US
[patent_app_date] => 2018-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16170165
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/170165 | Therapeutic inhibitor for EBV-associated tumor with tailor responsive optical imaging | Oct 24, 2018 | Issued |
Array
(
[id] => 18764238
[patent_doc_number] => 11814625
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-14
[patent_title] => Aptamers as a therapeutic tool to prevent protein aggregation in neurodegenerative disease
[patent_app_type] => utility
[patent_app_number] => 16/758090
[patent_app_country] => US
[patent_app_date] => 2018-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 30
[patent_no_of_words] => 18037
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16758090
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/758090 | Aptamers as a therapeutic tool to prevent protein aggregation in neurodegenerative disease | Oct 21, 2018 | Issued |
Array
(
[id] => 16756537
[patent_doc_number] => 10975073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Imaging methods using 2-hetaryl imidazol[1,2-a]pyridine derivatives
[patent_app_type] => utility
[patent_app_number] => 16/161306
[patent_app_country] => US
[patent_app_date] => 2018-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 15359
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16161306
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/161306 | Imaging methods using 2-hetaryl imidazol[1,2-a]pyridine derivatives | Oct 15, 2018 | Issued |
Array
(
[id] => 17665281
[patent_doc_number] => 11358962
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => 2-hetaryl imidazol[1,2-a]pyridine derivatives
[patent_app_type] => utility
[patent_app_number] => 16/161299
[patent_app_country] => US
[patent_app_date] => 2018-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 15664
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16161299
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/161299 | 2-hetaryl imidazol[1,2-a]pyridine derivatives | Oct 15, 2018 | Issued |
Array
(
[id] => 14833561
[patent_doc_number] => 20190275181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => Compounds for Positron Emission Tomography
[patent_app_type] => utility
[patent_app_number] => 16/157024
[patent_app_country] => US
[patent_app_date] => 2018-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16157024
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/157024 | Compounds for Positron Emission Tomography | Oct 9, 2018 | Abandoned |
Array
(
[id] => 14777919
[patent_doc_number] => 20190263857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => TOLL-LIKE RECEPTOR 2 LIGANDS AND METHODS OF MAKING AND USING THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/150496
[patent_app_country] => US
[patent_app_date] => 2018-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16150496
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/150496 | Toll-like receptor 2 ligands and methods of making and using thereof | Oct 2, 2018 | Issued |
Array
(
[id] => 16824438
[patent_doc_number] => 20210139731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => EPIDERMAL PENETRATION TYPE INK COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/755359
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2356
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16755359
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/755359 | Epidermal penetration type ink composition | Sep 30, 2018 | Issued |
Array
(
[id] => 16572186
[patent_doc_number] => 10894097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-19
[patent_title] => HER2 binders
[patent_app_type] => utility
[patent_app_number] => 16/145115
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 30
[patent_no_of_words] => 11280
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16145115
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/145115 | HER2 binders | Sep 26, 2018 | Issued |
Array
(
[id] => 16267426
[patent_doc_number] => 20200268913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => RADIOACTIVE DRUG
[patent_app_type] => utility
[patent_app_number] => 16/648703
[patent_app_country] => US
[patent_app_date] => 2018-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 245
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16648703
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/648703 | Metal complex forming compound, metal complex compound formed thereof, radioactive drug containing the metal complex compound, and method of using and preparing the metal complex compound | Sep 25, 2018 | Issued |
Array
(
[id] => 14227461
[patent_doc_number] => 20190125903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => UPAR TARGETING PEPTIDE FOR USE IN PEROPERATIVE OPTICAL IMAGING OF INVASIVE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/142977
[patent_app_country] => US
[patent_app_date] => 2018-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3323
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16142977
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/142977 | UPAR TARGETING PEPTIDE FOR USE IN PEROPERATIVE OPTICAL IMAGING OF INVASIVE CANCER | Sep 25, 2018 | Abandoned |
Array
(
[id] => 16282728
[patent_doc_number] => 20200276330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => USE OF RADIOLABELED NANOBODY IN PROGNOSIS AND DIAGNOSIS OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/647467
[patent_app_country] => US
[patent_app_date] => 2018-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8294
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647467
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647467 | Use of radiolabeled nanobody in prognosis and diagnosis of cancer | Sep 12, 2018 | Issued |
Array
(
[id] => 15616147
[patent_doc_number] => 20200078478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => Structural molecule of peptide derivative for PSMA-targeting radiotherapy diagnosis and treatment
[patent_app_type] => utility
[patent_app_number] => 16/125787
[patent_app_country] => US
[patent_app_date] => 2018-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 508
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16125787
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/125787 | Structural molecule of peptide derivative for PSMA-targeting radiotherapy diagnosis and treatment | Sep 9, 2018 | Abandoned |
Array
(
[id] => 16246025
[patent_doc_number] => 10745365
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
[patent_app_type] => utility
[patent_app_number] => 16/109146
[patent_app_country] => US
[patent_app_date] => 2018-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 72
[patent_no_of_words] => 61987
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16109146
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/109146 | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions | Aug 21, 2018 | Issued |
Array
(
[id] => 16288933
[patent_doc_number] => 10765756
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Cholecystokinin B receptor targeting for imaging and therapy
[patent_app_type] => utility
[patent_app_number] => 16/105734
[patent_app_country] => US
[patent_app_date] => 2018-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 32
[patent_no_of_words] => 21437
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16105734
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/105734 | Cholecystokinin B receptor targeting for imaging and therapy | Aug 19, 2018 | Issued |
Array
(
[id] => 14564221
[patent_doc_number] => 20190209717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/046786
[patent_app_country] => US
[patent_app_date] => 2018-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18444
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16046786
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/046786 | Compounds and methods for the detection of TRPV-6 cancers and drug delivery | Jul 25, 2018 | Issued |
Array
(
[id] => 15993405
[patent_doc_number] => 20200172573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => PEPTIDE AMIDE COMPOUND AND PREPARATION METHOD AND MEDICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/632228
[patent_app_country] => US
[patent_app_date] => 2018-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32697
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632228
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/632228 | Peptide amide compound and preparation method and medical use thereof | Jul 18, 2018 | Issued |
Array
(
[id] => 16157349
[patent_doc_number] => 20200216907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => METHODS FOR THERAPEUTICS PRESCREENING IN BODILY FLUIDS
[patent_app_type] => utility
[patent_app_number] => 16/628210
[patent_app_country] => US
[patent_app_date] => 2018-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16643
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16628210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/628210 | Methods for therapeutics prescreening in bodily fluids | Jul 4, 2018 | Issued |